152. New Vaccines: Friday, 12:15 - 1:30 p.m.
Poster Session: New Vaccines
Yasushi Fukushima, MD PhD
Fukuwa clinic
Chuo-ku, Tokyo, Japan
Jose F. Cardona, MD, JD, MBA-HA, FACLM
Principal Investigator, Medical Director
Indago Research & Health Center
Hialeah, Florida, United States
Agnieszka Zareba, MD PhD
Director Vaccines Research
Pfizer
Pearl RIver, New York, United States
Qin Jiang, PhD
Senior Director
Pfizer
Collegeville, Pennsylvania, United States
Daniel P. Eiras, MD, MPH
Associate Director
Pfizer, Inc.
Pearl River, New York, United States
Michael Patton, B.Sc.
Pfizer, Vaccine Research and Development
Hurley, England, United Kingdom
Kumar Ilangovan, MD, MSPH, MMCi (he/him/his)
Director, Clinician Medical Monitor
Vaccine Research and Development, Pfizer, USA
Raleigh, North Carolina, United States
Elliot N. DeHaan, MD
Associate Director
Pfizer
Pearly River, New York, United States
Tarek Mikati, MD,MPH
Associate Medical Director
3. Pfizer, Inc., Vaccine Research & Development
Pearl River, New York, United States
Elena Kalinina, PhD
Director
Pfizer
Pearl River, New York, United States
David Cooper, PhD
Senior Director
Pfizer
Pearl River, New York, United States
Kenneth Koury, PhD
Head of Statistics and Modeling
Pfizer
Pearl River, NY, United States
Annaliesa S. Anderson, PhD
SVP & CSO
Pfizer
New York, New York, United States
Kena A. Swanson, Ph.D.
Vice President, Viral Vaccines
Pfizer
Pearl River, New York, United States
.jpg "William C. Gruber, MD photo")
William C. Gruber, MD
SVP
Pfizer
Pearl River, New York, United States
Alejandra C. Gurtman, M.D.
Vice President
Pfizer
Pearl River, New York, United States
Beate Schmoele-Thoma, MD
Dr.
Pfizer
Pearl River, New York, United States